GTCR and ex-NuVasive chief launch Corza Medical through two-part surgical technology deal

Corza Medical snaps up Surgical Specialties and merges it with TachoSil – a carve-out from Japan's Takeda – to create a $300 million-plus revenue generating surgical technologies company.

To view this content, you need to sign in.


You should only be asked to sign in once. Not the case? Click here


Register now to access this content and more for free.

Share this